Home Subjects Financial Results

Financial Results

HealthCare Global Enterprises Ltd. reports Q3-FY18 results

Revenue for Q3 FY18 of INR 2,063 Million, a growth of 17% (y-o-y) and for 9M FY18 of INR 6,084 Million, a growth of 17.5% (y-o-y) EBITDA for Q3 FY18 at INR 319 Million, a growth of 15.3% (yo-y) and...

Dr. Reddy’s Q1 FY19 Financial Results

Hyderabad, July29, 2018: Dr. Reddy’s Laboratories Ltd. (BSE: 500124 | NSE:DRREDDY | NYSE: RDY) today announced its consolidated financial results for the quarter ended June30, 2018 under International Financial Reporting Standards (IFRS). Commenting on the results, Co-chairman and CEO, GV...

Dabur India profit up 16.4% at Rs. 282.8 crore

New Delhi, January, 2015 - Dabur India posted a consolidated net profit of Rs. 282.8 crore, up 16.4 per cent for the quarter ended December 31, 2014 against Rs. 242.9 crore in the corresponding quarter previous year. The company’s consolidated...

Natco Pharma Q3 net benefit up 12% at Rs 217.4 cr

New Delhi, February 08, 2018: The organization had posted a benefit after assessment of Rs 194.9 crore for the comparing time of the past monetary, Natco Pharma said in a BSE documenting. Medication firm Natco Pharma today detailed a 11.54...

Strides posts Rs.532-cr net in fiscal 2015

Bengaluru, May 27, 2015 Drug firm Strides Arcolab has posted a net profit of Rs.532.3 crore for the 2015 financial year, riding on the back of a spate of acquisitions made in the year, coupled with renewed focus on re-entering...

Testing on 42,000 drugs to ‘prove quality to world’

Mega survey will be completed in 6-8 months, says Drugs Controller Hyderabad, May 28, 2015: A mega survey involving testing of 42,000 samples of Indian drugs for quality will be completed in the next six to eight months, according to GN...

Fortis Narrows loss to Rs.45.8 Crore in Q1

NEW DELHI, AUGUST 9, 2014: Fortis Healthcare has narrowed its losses in the first quarter of this fiscal. The company posted a net loss of Rs.45.8 crore from Rs.221.3 crore posted during the quarter that ended June 30, 2014 in...

GSK reported turnover of £ 6.2 billion in the last quarter of 2014

New Delhi, Feb 07, 2015 -  GSK reported turnover of £ 6.2 billion in the last quarter of 2014, down a massive 8% from a year earlier and core earnings per share were down 6% at 27.2p. However despite the...

Aarti Industries Ltd. Q2FY15 Results

Mumbai, November 2014 -- Q2FY15 Total Income at Rs. 761.16 crore, Y-o-Y growth 18 % -- Q2FY15 Net Profit at Rs. 50.72 crore, Y-o-Y growth of 20 % -- Board declares interim dividend of Rs. 2.25 per share Editors’ Synopsis: For the Quarter ended...

Middle East and Africa pharma economy to reach US$38.8bn by 2021

CPhI Middle East & Africa opens in Abu Dhabi as finished dosage formulations expand quickly, driven by government reforms to further increase local manufacturing Amsterdam, August 15, 2018: CPhI MEA (Middle East and Africa) launches next month as favourable market conditions are...